¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"American visceral leishmaniasis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • visceral nerve
    ³»Àå½Å°æ
  • visceral nerve fiber
    ³»Àå½Å°æ¼¶À¯
  • visceral pain
    ³»ÀåÅëÁõ, Àå±âÅëÁõ
  • visceral pelvic fascia
    ³»ÀåÂʰñ¹Ý±Ù¸·, ÀåÃø°ñ¹Ý±Ù¸·
  • visceral peritoneum
    ³»ÀåÂʺ¹¸·, ³»ÀåÂʹ踷
  • visceral pleura
    ³»ÀåÂʰ¡½¿¸·, ³»ÀåÃøÈ丷
  • visceral reflex
    ³»Àå¹Ý»ç
  • visceral reflex arc
    ³»Àå¹Ý»çȰ, ³»Àå¹Ý»ç±Ã
  • visceral sense
    ³»Àå°¨°¢
  • visceral sensory neuron
    ³»Àå°¨°¢½Å°æ¼¼Æ÷
  • visceral surface
    ³»Àå¸é
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • visceral nerve
    ³»Àå½Å°æ
  • visceral motor nucleus
    ³»Àå¿îµ¿ÇÙ
  • visceral sensory neuron
    ³»Àå°¨°¢½Å°æ¼¼Æ÷
  • visceral pain
    ³»ÀåÅëÁõ, Àå±âÅëÁõ
  • visceral peritoneum
    ³»ÀåÂʹ踷, ³»ÀåÂʺ¹¸·
  • visceral pleura
    ³»ÀåÂʰ¡½¿¸·, ÇãÆÄÂʰ¡½¿¸·
  • visceral reflex
    ³»Àå¹Ý»ç
  • visceral sense
    ³»Àå°¨°¢
  • visceral surface
    ³»Àå¸é
  • visceral syphilis
    ³»Àå¸Åµ¶
  • visceral larva migrans
    ³»Àå¾Ö¹ú·¹ÀÌÇàÁõ, ³»ÀåÀ¯ÃæÀÌÇàÁõ
  • visceral
    ³»Àå-
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • French-American-British leukemia classification
    FAB ¹éÇ÷º´ºÐ·ù
  • Gilchrists disease => North American blastomycosis
    ºÏ¾Æ¸Þ¸®Ä« ºÐ¾Æ Áø±ÕÁõ
  • South American blastomycosis
    ³²¾Æ¸Þ¸®Ä«ºí¶ó½ºÅä¹Ì¼¼½ºÁø±ÕÁõ.
  • South American hemorrhagic fever
    ³²¾Æ¸Þ¸®Ä«ÃâÇ÷¿­
  • american Thoracic Society medium
    ¹Ì±¹¤¾ºÎÇÐȸ¹èÁö
  • american association of physicists in medicine (AA
    PM) ¹Ì±¹ÀÇÇй°¸®ÇÐȸ
  • american society of therapeutic radiology and onco
    logy (ASTRO) ¹Ì±¹¹æ»ç¼±Á¾¾çÇÐȸ
  • american trypanosomiasis
    ¾Æ¸Þ¸®Ä« Æ®¸®ÆÄ³ë¼Ò¸¶Áõ(¡­ñø), »þ °¡½ºº´(¡­Ü»)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • leishmaniasis
    ¸®½´¸¶´Ï¾ÆÁõ
  • leishmaniasis
    ¸®½´¸¶´Ï¾ÆÁõ, ¸®½´¸¶´Ï¾Æº´(Ü»)
  • leishmaniasis recidiva
    Àç¹ß¼º ¸®½´¸¶´Ï¾ÆÁõ.
  • leishmaniasis recidivans
    Àç¹ß¼º ¸®½´¸¶´Ï¾ÆÁõ
  • lymphocutaneous leishmaniasis
    ÇǺθ²ÇÁ¼º¸®½´¸¶´Ï¾ÆÁõ
  • mucocutaneous leishmaniasis
    ÇǺΠÁ¡¸·¸®½´¸¶´Ï¾ÆÁõ
  • oriental sore => Leishmaniasis
  • post-kala-azar leishmaniasis
  • viseral leishmaniasis
  • autonomic fibers visceral fibers
    ÀÚÀ²½Å°æ¼¶À¯ ³»Àå½Å°æ¼¶À¯
  • autonomic ganglion visceral ganglion
    ÀÚÀ²½Å°æÀý ³»Àå½Å°æÀý
  • larva migrans, visceral
    À¯Ãæ³»ÀåÀÌÇàÁõ(êêõùÒ®íô ì¹ú¼ñø)
  • plexus of visceral veins
    ³»ÀåÁ¤¸Æ¾ó±â
  • referred visceral pain
    ³»À忬°üÅë.
  • referred visceral pain
    ³»À忬°üÅë(Ò®íôæáμ÷Ô)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ACA abnormal coronary artery; acrodermatitis chronica atrophicans; acute cerebellar ataxia; adenocarcino...
AES acetone-extracted serum; American Electroencephalographic Society; American Encephalographic Society...
DCL dicloxacillin; diffuse or disseminated cutaneous leishmaniasis
ACP accessory conduction pathway; acid phosphatase; acyl carrier protein; American College of Pathologis...
AAN AIDS-associated nephropathy; alpha-amino nitrogen; American Academy of Neurology; American Academy o...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
"DCL" Diffuse Cutaneous Leishmaniasis
LCL Localized cutaneous leishmaniasis
MCL Mucocutaneous leishmaniasis
PKDL Post kala-azar dermal leishmaniasis
ZCL Zoonotic cutaneous leishmaniasis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • visceral afferent nociceptor
    ³»Àå ±¸½É¼º À¯Çؼö¿ë±â
  • visceral form
    ³»ÀåÇü
  • visceral larva migrans

    visceral lesion (³»Àå º´¼Ò

  • visceral muscle
    ³»Àå±Ù
    ¼ÒÈ­±â, ½ÉÀå, ±× ¹ÛÀÇ ³»ÀåÀÇ ºÒ¼öÀÇ ¿îµ¿¿¡ °ü¿©ÇÏ´Â ±ÙÀ°. °ñ°Ý±Ù¿¡ ´ëÀÀµÇ´Â ¸»ÀÌ´Ù. °ñ°Ý±ÙÀÌ ±¸°£
  • visceral nerve
    ³»Àå½Å°æ
    ±³°¨½Å°æ°è¿¡ ¼ÓÇÏ´Â º¹ºÎ ³»ÀåÀ» Áö¹èÇÏ´Â ½Å°æ. ±× Áß¿¡´Â Ç÷°üº®ÀÇ ¿îµ¿, ¹Î¹«´Ì±ÙÀÇ ¿îµ¿, ¼±ÀÇ ºÐºñ¸¦ °üÀåÇÏ´Â ¼¶À¯¸¦ Æ÷ÇÔÇϰí ÀÖ´Ù. ´ë³»Àå½Å°æÀº Á¦5~9Èä½Å°æÀýÀÇ ³»ÀåÁö°¡ ¸ðÀÎ °ÍÀ̰í, ¼Ò³»Àå½Å°æÀº ´ë³»Àå½Å°æÀÇ ¾Æ·¡¿¡ À̾îÁ®¼­ º¸ÅëÀº Á¦10~12 Èä½Å°æÀýÀÇ ³»ÀåÁö¿¡ ¸ð¿© ÀÖ´Ù. ¸ðµÎ ôÃß ¾çÂÊ¿¡ ºÙ¾î ÇÏÀü¹æÀ¸·Î »¸¾î³ª°¡ Ⱦ°Ý¸·À» ¶Õ°í °ð¹Ù·Î º¹°­½Å°æÃÑÀ¸·Î µé¾î°£´Ù. ´ë³»Àå½Å°æ ¼Ó¿¡ ÀÖ´Â ¼¶À¯´Â À§, ¼ÒÀå, ´ëÀå, ´ëÀå»óºÎ, °£, ÀÌÀÚ, Áö¶ó µî¿¡ ºÐÆ÷Çϸç, ¼Ò³»Àå½Å°æ ¼ÓÀÇ ¼¶À¯´Â ÁÖ·Î ½ÅÀå, ºÎ½Å¿¡ ºÐÆ÷µÇ¾î ÀÖ´Ù. ´ë³»Àå½Å°æ ¼Ó¿¡´Â ´Ù·®ÀÇ Áö°¢¼º À¯¼ö¼¶À¯°¡ Æ÷ÇԵǾîÀ־ ±×°ÍÀÌ º¹ºÎ³»ÀåÀÇ Áö°¢À» À¯µµÇϴµ¥, À̰ÍÀº ±³°¨½Å°æÀÌ ¾Æ´Ï°í ±³ÅëÁö¸¦ ÅëÇØ¼­ ¿À´Â ô¼ö½Å°æ ¼¶À¯ÀÌ´Ù. ÀÌ ¹Û¿¡ º¹ºÎ ±³°¨½Å°æ°£ÀÇ ¿ä½Å°æÀý¿¡¼­ ³ª¿À´Â ³»ÀåÁö¸¦ õ°ñ ³»Àå½Å°æÀ̶ó°í ºÎ¸£´Âµ¥, À̰͵éÀº ÇÏÇà°áÀå ÀÌÇÏÀÇ Àå°ü, °ñ¹Ý³»Àå, ¿ÜÀ½ºÎ µî¿¡ ºÐÆ÷ÇÑ´Ù. ±×¸®°í ô¼ö½Å°æÀÇ Ãµ°ñ½Å°æ¿¡¼­ ³ª¿À´Â ºÎ±³°¨¼º ³»ÀåÁö
  • visceral nociception
    ³»Àå À¯ÇØÀÎÁö
  • visceral organ
    ³»Àå ±â°ü
  • visceral pain
    ³»Àå ÅëÁõ, ³»ÀåÅë, ³»À强 µ¿Åë
    Á¡¸· Çǰ³, ³»Àå º®, ±â°üÀÇ ½ÇÁú
  • visceral pharyngeal arches
    ³»Àå ÀεαÃ
  • visceral receptor
    ³»Àå ¼ö¿ë±â
  • visceral sensation
    ³»Àå °¨°¢
  • visceral sensory system
    ³»Àå °¨°¢°è
  • visceral stimulus
    ³»Àå ÀÚ±Ø
    ³»ºÎ Àå±â¸¦ ÀÚ±ØÇÏ´Â °Í.
  • visceral swallow
    Àå±â¼º ¿¬ÇÏ, ³»À强 ¿¬ÇÏ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
American Type Culture Collection <cell culture> A key resource for cultured cells, located in Rockville, USA.
(12 Dec 1998)
pan american health organization <organisation> WHO regional office for the americas acting as a coordinating agency for the improvement of health conditions in the hemisphere.
The four main functions are: control or eradication of communicable diseases, strengthening of national and local health services, education and training, and research.
(21 Jun 2000)
haemorrhagic fever, american Diseases caused by american haemorrhagic fever viruses (tacaribe complex viruses).
(12 Dec 1998)
south american blastomycosis A chronic fungal infection caused by Paracoccidioides brasiliensis, characterised by primary pulmonary lesions with dissemination to many visceral organs. Common findings include ulcerative granuloma lesions to the buccal mucosa (inner lining of the cheek) and nasal mucosa that extend to the surrounding skin. Generalised lymphangitis is also typical. More commonly seen in South America and the tropics.
(27 Sep 1997)
South American trypanosomiasis Trypanosomiasis caused by Trypanosoma (or Schizotrypanum) cruzi and transmitted by certain species of reduviid (triatomine) bugs. In its acute form, it is seen most frequently in young children, with swelling of the skin at the site of entry, most often the face, and regional lymph node enlargement; in its chronic form it can assume several aspects, commonly cardiomyopathy, but megacolon and megaesophagus also occur; natural reservoirs include dogs, armadillos, rodents, and other domestic, domiciliated, and wild mammals.
Synonym: Chagas' disease, Chagas-Cruz disease, Cruz trypanosomiasis.
(05 Mar 2000)
North American blastomycosis A fungal infection caused by Blastomyces dermatitidis. This rare fungal infection may produce inflammatory lesion of the skin or lungs or present as a disseminated disease to the skin, lungs, bones, liver, spleen and central nervous system. Uncommon unless patient is immunocompromised (AIDS).
(27 Sep 1997)
indians, central american An ethnic group belonging to the mongoloid racial stock in central america. This does not include mexican indians.
(12 Dec 1998)
indians, north american An ethnic group belonging to the mongoloid racial stock in north america.
(12 Dec 1998)
indians, south american An ethnic group belonging to the mongoloid racial stock in south america.
(12 Dec 1998)
oil of American wormseed Volatile oil from the fresh above ground part of the flower, American wormseed, Chenopodium ambrosioides, or C. Anthelminticum. Used as an anthelmintic.
Synonym: oil of American wormseed.
(05 Mar 2000)
French-American-British classification <haematology> The classification of acute myeloid leukaemia on the basis of bone marrow and peripheral blood features.
M0: Acute myeloid leukaemia with minimal evidence of myeloid differentiation.
M1: Acute myeloblastic leukaemia.
M2: Acute myeloblastic leukaemia with differentiation.
M3: Acute promyelocytic leukaemia.
M4: Acute myelomonocytic leukaemia.
M5: Acute monocytic leukaemia.
M6: Acute erythroleukaemia.
M7: Acute megakaryocytic leukaemia.
Acronym: FAB
(07 Apr 1998)
acute cutaneous leishmaniasis A form of cutaneous leishmaniasis characterised by rural distribution of human cases near infected rodents, particularly communal ground squirrels; characterised by acute rapidly developing dermal lesions that become severely inflamed, with moist necrotizing sores or ulcers that heal in two to eight months after a two to four month incubation period; among nonimmune immigrants, multiple lesions may develop, which heal more slowly and leave disabling or disfiguring scars. A strong delayed hypersensitivity and involvement of immune complexes play a role in necrosis, which is part of the healing process and of the strong specific immunity that follows.
Synonym: acute cutaneous leishmaniasis, rural cutaneous leishmaniasis, wet cutaneous leishmaniasis.
(05 Mar 2000)
anergic leishmaniasis Leishmaniasis caused by several New and Old World species and strains of Leishmania (L. Mexicana amazonensis, L. M. Pifanoi, possibly L. M. Garnhami and L. M. Venezuelensis; in Ethiopia, L. Aethiopica, and unidentified leishmanial agents in Namibia and Tanzania). The condition is associated with a suppressed cell-mediated immune response, so that the non-ulcerating, non-necrotizing cutaneous lesions can spread widely over the body; great numbers of parasite-filled macrophages are found in the dermal lesions. Healing does not appear to occur unless an acquired cellular hypersensitivity can develop.
Synonym: anergic leishmaniasis, diffuse leishmaniasis, disseminated cutaneous leishmaniasis, leishmaniasis tegumentaria diffusa, pseudolepromatous leishmaniasis.
(05 Mar 2000)
anthroponotic cutaneous leishmaniasis A form of Old World cutaneous leishmaniasis, usually with a prolonged incubation period and confined to urban areas.
Synonym: chronic cutaneous leishmaniasis, dry cutaneous leishmaniasis, urban cutaneous leishmaniasis.
(05 Mar 2000)
canine leishmaniasis A mild infection of dogs, usually confined to the muzzle or ears, produced by human disease-causing species of Leishmania; dogs therefore are important reservoirs of human infection, such as with visceral leishmaniasis in the Mediterranean region.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • General American
    ÀÏ¹Ý ¹Ì±¹ ¿µ¾î(¹Ì±¹ New England Áö¹æ ¹× ³²ºÎ¸¦ Á¦¿ÜÇÑ Àü¿ª¿¡¼­ ÀÏ»ó »ç¿ëµÇ°í ÀÖ´Â ¿µ¾î)
  • Irish American
    ¾ÆÀÏ·£µå°è ¹Ì±¹ÀÎ
  • Native American
    (¹Ì)¾Æ¸Þ¸®Ä­ Àεð¾ð(ÀÇ)
  • North American
    ºÏ¹ÌÀÇ (»ç¶÷)
  • modified American plan
    º¯Çü ¹Ì±¹ ¹æ½Ä(´ë½Ç·á,Á¶¼® ½Ä´ë¸¦ ¸ÅÀÏ(¸ÅÁÖ) Á¤¾×À¸·Î û±¸Çϴ ȣÅÚ ¿ä±Ý Á¦µµ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á